Emile Foucat

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat The control of the false discovery rate in multiple testing under dependency 2001 Yoav Benjamini
Daniel Yekutieli
1
+ PDF Chat Unique human immune signature of Ebola virus disease in Guinea 2016 Paula Ruibal
Lisa Oestereich
Anja LĂŒdtke
Beate Becker‐Ziaja
David M. Wozniak
Romy Kerber
MiĆĄa Korva
Mar Cabeza-Cabrerizo
Joseph Akoi Boré
Fara Raymond Koundouno
1
+ PDF Chat Comprehensive characterization of cellular immune responses following Ebola virus infection 2016 Christine Dahlke
Sebastian Lunemann
Rahel Kasonta
Benno Kreuels
Stefan Schmiedel
My Linh Ly
Sarah K. Fehling
Thomas Strecker
Stephan Becker
Marcus Altfeld
1
+ PDF Chat Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea 2017 Fabien Subtil
Charlotte LaniĂšce Delaunay
Alpha Kabinet KeĂŻta
Mamadou Sow
Abdoulaye Touré
Sandrine Leroy
Philippe Msellati
N’Fally Magassouba
Sylvain Baize
Hervé Raoul
1
+ PDF Chat Serological Evidence of Ebola Virus Infection in Rural Guinea before the 2014 West African Epidemic Outbreak 2018 Alpha Kabinet KeĂŻta
Christelle Butel
Guillaume Thaurignac
Aminata Diallo
Talla Nioké
Falaye Traoré
Lamine Koivogui
Martine Peeters
Éric Delaporte
Ahidjo Ayouba
1
+ Correlates of vaccine-induced protective immunity against Ebola virus disease 2018 Donata Medaglini
Francesco Santoro
Claire‐Anne Siegrist
1
+ PDF Chat Immune parameters and outcomes during Ebola virus disease 2019 Stéphanie Reynard
Alexandra Journeaux
Emilie Gloaguen
Justine Schaeffer
Hugo Varet
Natalia Pietrosemoli
Mathieu Mateo
Nicolas Baillet
Cédric Laouénan
Hervé Raoul
1
+ PDF Chat Long-lasting severe immune dysfunction in Ebola virus disease survivors 2020 Aurélie Wiedemann
Emile Foucat
Hakim Hocini
CĂ©cile Lefebvre
Boris P. Hejblum
MĂ©lany Durand
Miriam KrĂŒger
Alpha Kabinet KeĂŻta
Ahidjo Ayouba
Stéphane Mély
1
+ PDF Chat Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins 2020 Till Koch
Monika Rottstegge
Paula Ruibal
Sergio Gómez‐Medina
Emily V. Nelson
Beatriz Escudero-PĂ©rez
Matthias Pillny
My Linh Ly
Fara Raymond Koundouno
Joseph Akoi Boré
1
+ PDF Chat Understanding Long-term Evolution and Predictors of Sequelae of Ebola Virus Disease Survivors in Guinea: A 48-Month Prospective, Longitudinal Cohort Study (PostEboGui) 2021 Mamadou Saliou Kalifa Diallo
Abdoulaye Touré
Mamadou Sow
Cécé Kpamou
Alpha Kabinet KeĂŻta
Bernard Taverne
Martine Peeters
Philippe Msellati
Thierno Alimou Barry
Jean-François Étard
1
+ PDF Chat Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study 2021 Mamadou Saliou Kalifa Diallo
Ahidjo Ayouba
Alpha Kabinet KeĂŻta
Guillaume Thaurignac
Mamadou Sow
Cécé Kpamou
Thierno Alimou Barry
Philippe Msellati
Jean-François Étard
Martine Peeters
1
+ Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo 2022 Marie Jaspard
Sabue Mulangu
Sylvain Juchet
BĂ©atrice Serra
Ibrahim Dicko
Hans-Joeg Lang
Baweye Mayoum Baka
Gaston Musemakweli Komanda
Jeremie Muhindo Katsavara
Patricia Kabuni
1
+ PDF Chat Randomized Trial of Vaccines for Zaire Ebola Virus Disease 2022 Mark Kieh
Laura Richert
Abdoul Habib BĂ©avogui
Birgit Grund
Bailah Leigh
Éric D’Ortenzio
Seydou Doumbia
Edouard Lhomme
Samba O. Sow
Renaud Vatrinet
1
+ PDF Chat Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014–2016 Outbreak in West Africa 2019 Francesca Colavita
Mirella Biava
Concetta Castilletti
Simone Lanini
Rossella Miccio
Gina Portella
Francesco Vairo
Giuseppe Ippolito
Maria Rosaria Capobianchi
Antonino Di
1
+ PDF Chat Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans 2023 Chelsea McLean
Karin Dijkman
Auguste Gaddah
Babajide Keshinro
Michael Katwere
Macaya Douoguih
Cynthia Robinson
Laura Solforosi
Dominika N. Czapska-Casey
Liesbeth Dekking
1
+ PDF Chat Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 2023 Angela Huttner
Sélidji Todagbé Agnandji
Olivier Engler
Jay W. Hooper
Steve Kwilas
Keersten M. Ricks
Tamara L. Clements
Hulda R. JĂłnsdĂłttir
Sravya Sowdamini Nakka
Sylvia Rothenberger
1
+ Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo 2024 Rebecca M. Coulborn
Mathieu Bastard
Nicolas Peyraud
Etienne Gignoux
Francisco J. Luquero
BĂ©rengĂšre Guai
Stéphane Hans Bateyi Mustafa
Elisabeth Mukamba Musenga
Steve Ahuka‐Mundeke
1